Veterinary Medicines

BioSuis Salm, Emulsion for injection

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Derby, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
Download as PDF

Product identification

Medicine name:
BioSuis Salm, Emulsion for injection
FIXR Salmonella Emulsie voor injectie
FIXR Salmonella Emulsion injectable
FIXR Salmonella Emulsion zur Injektion
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Derby, Inactivated
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
Target species:
  • Pig (pregnant sow)
  • Pig (pregnant gilt)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Salmonella enterica, subsp. enterica, serovar Derby, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
  • Salmonella enterica, subsp. enterica, serovar Infantis, strain A S03499-06, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (pregnant sow)
      • Meat and offal
        0
        day
    • Pig (pregnant gilt)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB14
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Glass Vial 1 x 10.0 Dose
  • Plastic Vial 1 x 50.0 Dose
  • Plastic Vial 1 x 100.0 Dose
  • Glass Vial 10 x 10.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta, a.s.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0151/001
Concerned member states:
  • Austria
  • Belgium
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."